[VSsupport]

<img alt="" height="1" width="1" />Synergy Pharmaceuticals Raises $8.6 Million in Common Stock FinancingEarthtimes (press release)SP-304 is a member of a new class of non-systemic drugs for treatment of chronic constipation (CC), irritable bowel syndrome with constipation (IBS-C) and ...<nobr>and more »</nobr>

View the full article